Ajanta Pharma USA Inc recalls Fenofibrate Capsules
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations
- Products
-
- Fenofibrate Capsules
- Company
- Ajanta Pharma USA Inc
- Where it was sold
-
U.S. Nationwide
Nationwide
- Units affected
- 3648 bottles
- About this recall
- Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04.